IB Infotech net profit drops 56% in Q1; revenue falls 34%
Nano-cap's net profit fell to ₹37.67 lakhs from ₹85.10 lakhs a year ago, with revenue at ₹149.41 lakhs. A weak start to FY27 with no forward guidance.
What's new
- Net profit dropped to ₹37.67 lakhs from ₹85.10 lakhs a year ago, a 56% decline.
- Revenue fell 34% to ₹149.41 lakhs from ₹226.52 lakhs.
- Auditors gave an unmodified review; no new strategic actions announced.
Why this matters
For a ₹57-cr market cap company, a 56% profit drop is a material miss. But routine quarterly filings carry limited surprise for nano-caps: the market already had the weak top-line trend in price. The unmodified audit opinion removes one worry, but the lack of any forward-looking commentary leaves the investment thesis unchanged.
What we're watching
- Whether management provides any revenue outlook in the next concall.
- If the trailing ROE of 30.6% can sustain given the earnings decline.
- Any change in auditor stance or corporate action in the coming quarters.
The full read
IB Infotech Enterprises just reported its worst quarter in a year. Net profit dropped 56% to ₹37.67 lakhs; revenue slumped 34% to ₹149.41 lakhs. The numbers confirm what the trailing -78.7% revenue growth already signalled: demand isn't there yet. Not yet. The auditors signed off clean, so no governance sting. But for a ₹57-cr nano-cap trading at 33x trailing earnings, the multiple demands a recovery the filing doesn't promise — and without forward guidance or new orders, the weak start to FY27 is now official, leaving the stock to wait for a catalyst that may not come this quarter.
Questions answered
- How much did IB Infotech's net profit fall in Q1 FY27?
- Net profit dropped 56% to ₹37.67 lakhs from ₹85.10 lakhs in the same quarter last year.
- What was the revenue figure and how does it compare?
- Revenue fell 34% to ₹149.41 lakhs from ₹226.52 lakhs a year earlier.
- Did auditors raise any concerns?
- No. The statutory auditors issued a limited review report with an unmodified conclusion, meaning no adverse observations.
- Is this filing likely to move the stock?
- Unlikely. The results are backward-looking and routine for a nano-cap; the market had already priced in the weak start.